Drugstore chain is closing underperforming stores as it struggles with a weak consumer, pressure on pharmacy margins.
Walgreens Boots Alliance (WBA) shares crashed to their lowest level since 1997 on Thursday as the big pharmacy chain and healthcare provider missed profit estimates, slashed guidance, and planned major location closings because of weak consumer demand.
Walgreens Boots Alliance, Inc. shares are plummeting due to operational problems, theft, competition, and changing dynamics in the pharmacy space. Despite revenue growth in all segments, the company's profitability is declining, with a significant decrease in adjusted net earnings and EPS. Management must make very tough decisions.
New jobless claims shrank a tad, but longer-term came in the highest in 2 1/2 years.
Shares of Walgreens Boots Alliance Inc. experienced a significant drop on Thursday following the release of its earnings report, plummeting to levels not seen since 1997. The company attributed the decline to persistent pressures on the US consumer and adverse marketplace dynamics that have negatively impacted pharmacy margins.
The headline numbers for Walgreens (WBA) give insight into how the company performed in the quarter ended May 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Walgreens announced Thursday that it's planning to close a number of underperforming stores as it contends with a tough economic environment and declining margins.
Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.63 per share, missing the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $1 per share a year ago.
Adjusted earnings at the drugstore chain miss analysts' estimates.
Walgreen Boots Alliance cut its profit forecast for fiscal 2024 and announced store closures on Thursday, citing challenging pharmacy industry trends and a worse-than-expected U.S. consumer environment.
Walgreens Boots Alliance Inc (NASDAQ: WBA) trading down this morning after reporting weaker-than-expected financial results for its third quarter. Shares of the healthcare giant are now down close to 50% for the year.